Meta-[18F]fluorobenzylguanidine ([18F]mFBG) PET-CT is a novel diagnostic imaging modality to detect norepinephrine transporter (NET)-expressing tumours, such as neuroblastoma and phaeochromocytoma [1]. The gene discussed is SLC6A2; the disease is neuroblastoma.